Impax Laboratories Inc. (Nasdaq: IPXL) named Paul M. Bisaro to the position of president and chief executive officer. Shares of the specialty pharmaceutical leaped $3.45 to close at $12.70.
Impax Laboratories names CEO
March 27, 2017 at 18:10 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.